The Drug Discovery and Experimental Therapeutics PhD program offers a unique educational opportunity for students interested in drug discovery and the development of novel therapeutics. The changing landscape of drug discovery and the pharmaceutical industry has created a need for scientists with interdisciplinary training to navigate the complex landscape of medicinal chemistry, biotherapeutics, pharmacogenetics/genomics, and basic pharmacology/toxicology. Students completing this program will have invaluable expertise from carefully selected coursework, a breadth of electives, and engagement in cutting-edge research.

This program prepares students for careers in academia, the pharmaceutical industry, biotechnology companies, regulatory agencies and government.

Our program offers full support for highly qualified applicants, including coverage of tuition and fees as well as a generous monthly stipend. Typical time to degree is 4.5 - 5.5 years.

All students entering the program will participate in a minimum of 2 rotations, each lasting 6-8 weeks, prior to joining a research group. Assignment of a student to a research group/mentor will occur following the completion of rotations based on mutual agreement by the student, advisor, and subprogram director.